Results 201 to 210 of about 7,228,361 (402)

IMMUNOHISTOCHEMICAL EXPRESSION OF p53 AND BCL-2 PROTEINS IN ADVANCED ESOPHAGEAL CANCER PATIENTS

Acta Medica Iranica, 2005
The current challenges in the management of esophageal cancer are to obtain a better understanding of underlying molecular alterations to provide new treatment options. We studied the p53 and Bcl-2 protein expression in esophageal carcinomas to correlate
S. Arbabi Bidgoli, B. Minaee, M. H. Ghahremani, S. N. Ostad, M. Djamali-Zavarei E. Azizi   +4 more
doaj  

997 USE OF MOLECULAR MARKERS IN BREEDING FOR RESISTANCE TO FUNGAL PATHOGENS

, 1994
James D. Kell
openalex   +1 more source

Genetic Variability ofLepidium meyeniiand other AndeanLepidiumSpecies (Brassicaceae) Assessed by Molecular Markers [PDF]

, 1998
J Toledo, Paramvir Dehal, F. Jarrín, J. Hu, M. Hermann, Ihsan Al-Shehbaz, Carlos F. Quirós   +6 more
openalex   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

No evidence of molecular markers of piperaquine resistance in southeastern Nigeria. [PDF]

Malar J
Ikegbunam M, Tzirtziganis V, Rodi M, Anagu L, Pessanha de Carvalho L, Inoue J, Held J.   +6 more
europepmc   +1 more source

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source

MRI features predict survival and molecular markers in diffuse lower-grade gliomas

Neuro-Oncology, 2017
Hao Zhou, M. Vallières, H. Bai, Chang Su, Haiyun Tang, D. Oldridge, Zishu Zhang, B. Xiao, W. Liao, Y. Tao, Jian-hua Zhou, Paul J Zhang, Li Yang   +12 more
semanticscholar   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

Identification of High- and Low-Cadmium (Cd)-Accumulating Rice Cultivars Using Combined Molecular Markers. [PDF]

Plants (Basel)
Wang C, Ding F, Rong Q, Lu Z, Fu J, Zhou C.   +5 more
europepmc   +1 more source

PCR derived molecular markers and phylogenetic relationships in theSecale genus [PDF]

, 1995
Juan C. del Pozo, A. M. Figueiras, C. Benito, Aurora de la Peña-Dı́az   +3 more
openalex   +1 more source